from the AACR 2010 Annual Meeting
WASHINGTON, D.C. — Scientists are methodically unlocking the biological processes that lead to cancer, and recent discoveries with microRNAs (miRNAs) are revolutionizing their understanding and leading to clinical trials of potentially effective treatments.
Nobel Laureate Phillip A. Sharp, Ph.D., institute professor at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, Cambridge, hosted a press conference on some of the recent research on miRNAs unveiled at the American Association for Cancer Research 101st Annual Meeting 2010.
“These abstracts are part of a revolution in cell biology that began in 2001 when the importance of miRNAs was recognized,” said Sharp. “The science of miRNAs and related small RNAs will continue to generate new insights into cancer and possible future treatments.”
The press conference was held on Monday, April 19
Several abstracts were presented at the press conference.
Listen here to the teleconference (53:10 minutes) or download the MP3 file.